Related Experiment Videos
Surgical reintervention for differentiated thyroid cancer
P E Goretzki1, D Simon, A Frilling
1Klinik für Allgemeine und Unfallchirurgie, Heinrich Heine Universität, Düsseldorf, Germany.
The British Journal of Surgery
|August 1, 1993
Summary
Reoperation for differentiated thyroid carcinoma is often necessary due to persistent or recurrent cancer. Surgical reintervention is the preferred treatment, aiming for complete tumor removal to improve patient outcomes.
Area of Science:
- Endocrinology
- Surgical Oncology
- Oncology
Background:
- Differentiated thyroid carcinoma (DTC) can require reoperation for persistent or recurrent disease.
- Identifying the reasons for reoperation is crucial for effective management.
Purpose of the Study:
- To evaluate the outcomes of reoperation in patients with differentiated thyroid carcinoma.
- To assess the efficacy of surgical reintervention for persistent and recurrent DTC.
Main Methods:
- Retrospective analysis of 110 patients undergoing reoperation for differentiated thyroid carcinoma.
- Categorization of indications for reoperation: large thyroid remnant versus suspected persistent/recurrent cancer.
- Histopathological examination of resected tissues and assessment of follow-up data.
Main Results:
- Reoperation was performed in 110 patients; 77% were for suspected persistent or recurrent cancer.
- No cancer was found in 29% of reoperated patients. Resectable tumor tissue was found in 30%.
- Recurrent tumors showed less differentiation in 13/38 patients, highlighting the need for complete clearance. Eight of 21 patients with macroscopic residual tumor died.
Conclusions:
- Surgical reintervention is the primary treatment for persistent and recurrent differentiated thyroid carcinoma.
- Complete tumor clearance during reoperation is essential for improving survival and preventing dedifferentiation.
- Radioiodine and radiation therapy should be considered after surgical options are exhausted.